{"entity":{"type":"insider","cik":"0001888273","url":"/insider/0001888273","json_url":"/insider/0001888273.json","name":"Leider Harry L.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":5,"n_filings":3,"first":"2023-06-30","last":"2023-12-21","span_basis":"filed_date"},"name_variants":[{"name":"Leider Harry L.","source":"filing","n_filings":3,"first_seen":"2023-06-30","last_seen":"2023-12-21"}],"transactions":[{"id":8346349,"accession":"0001829126-23-008139","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001829126-23-008139","line_url":"/filing/0001829126-23-008139#line-1","is_derivative":false,"issuer_cik":"0001557376","issuer_name":"Organicell Regenerative Medicine, Inc.","issuer_ticker":"OCEL","issuer_name_source":null,"issuer_url":"/issuer/0001557376","owner_cik":"0001888273","owner_name":"Leider Harry L.","owner_display_name":"Leider Harry L.","owner_url":"/insider/0001888273","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5248.0,"shares_display":"5,248","price_per_share":1.315,"price_display":"1.32","price_state":"stated","total_value":6901.12,"total_display":"6,901.12","total_whole":"6,901","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-12-19","filed_date":"2023-12-20","scope":"insider"},{"id":9296318,"accession":"0001829126-23-008158","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001829126-23-008158","line_url":"/filing/0001829126-23-008158#line-2","is_derivative":false,"issuer_cik":"0001557376","issuer_name":"Organicell Regenerative Medicine, Inc.","issuer_ticker":"OCEL","issuer_name_source":null,"issuer_url":"/issuer/0001557376","owner_cik":"0001888273","owner_name":"Leider Harry L.","owner_display_name":"Leider Harry L.","owner_url":"/insider/0001888273","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":500000.0,"shares_display":"500,000","price_per_share":0.01,"price_display":"0.01","price_state":"stated","total_value":5000.0,"total_display":"5,000.00","total_whole":"5,000","shares_owned_after":1049450.0,"shares_owned_after_display":"1,049,450","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-06-29","filed_date":"2023-12-21","scope":"insider"},{"id":8490455,"accession":"0001829126-23-004521","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001829126-23-004521","line_url":"/filing/0001829126-23-004521#line-2","is_derivative":false,"issuer_cik":"0001557376","issuer_name":"Organicell Regenerative Medicine, Inc.","issuer_ticker":"OCEL","issuer_name_source":null,"issuer_url":"/issuer/0001557376","owner_cik":"0001888273","owner_name":"Leider Harry L.","owner_display_name":"Leider Harry L.","owner_url":"/insider/0001888273","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":500000.0,"shares_display":"500,000","price_per_share":0.01,"price_display":"0.01","price_state":"stated","total_value":5000.0,"total_display":"5,000.00","total_whole":"5,000","shares_owned_after":1049450.0,"shares_owned_after_display":"1,049,450","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-06-29","filed_date":"2023-06-30","scope":"insider"},{"id":9296319,"accession":"0001829126-23-008158","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001829126-23-008158","line_url":"/filing/0001829126-23-008158#line-1","is_derivative":false,"issuer_cik":"0001557376","issuer_name":"Organicell Regenerative Medicine, Inc.","issuer_ticker":"OCEL","issuer_name_source":null,"issuer_url":"/issuer/0001557376","owner_cik":"0001888273","owner_name":"Leider Harry L.","owner_display_name":"Leider Harry L.","owner_url":"/insider/0001888273","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":549450.0,"shares_display":"549,450","price_per_share":0.0099,"price_display":"0.01","price_state":"stated","total_value":5439.555,"total_display":"5,439.56","total_whole":"5,440","shares_owned_after":549450.0,"shares_owned_after_display":"549,450","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-06-28","filed_date":"2023-12-21","scope":"insider"},{"id":8490452,"accession":"0001829126-23-004521","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001829126-23-004521","line_url":"/filing/0001829126-23-004521#line-1","is_derivative":false,"issuer_cik":"0001557376","issuer_name":"Organicell Regenerative Medicine, Inc.","issuer_ticker":"OCEL","issuer_name_source":null,"issuer_url":"/issuer/0001557376","owner_cik":"0001888273","owner_name":"Leider Harry L.","owner_display_name":"Leider Harry L.","owner_url":"/insider/0001888273","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":549450.0,"shares_display":"549,450","price_per_share":0.099,"price_display":"0.10","price_state":"stated","total_value":54395.55,"total_display":"54,395.55","total_whole":"54,396","shares_owned_after":549450.0,"shares_owned_after_display":"549,450","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-06-28","filed_date":"2023-06-30","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":5,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":4,"open_market":true},{"code":"S","label":"Open-market sale","n":1,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":5},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001557376","name":"Organicell Regenerative Medicine, Inc.","url":"/issuer/0001557376","role":"Director, Officer (Chief Executive Officer)","n_filings":3,"first_seen":"2023-06-30","last_seen":"2023-12-21"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001888273","retrieved_at":"2026-08-26T02:01:54+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}